Followers | 199 |
Posts | 25041 |
Boards Moderated | 0 |
Alias Born | 04/03/2010 |
Tuesday, May 21, 2024 3:13:23 AM
Things are not always absolute, in the way we might expect. But as I said, I am not claiming it is a standalone approval. It’s an immuno-stimulant and it would make sense if, having so much data that indicates it is not a risk for safety, regulators were OK with it when it’s addition to a therapy performed as expected, as an immune stimulant and PAMP.
But I’m no ideologue. I also said I do not think it matters at the moment. DCVax-L is seeking approval as its own treatment that is part of the SOC. Their application does not require poly-iclc to be approvable.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM